Is Thymoglobulin or Rituximab the Cause of This Serum Sickness? A Case Report of Serum Sickness Dilemma and Literature Review

Serum sickness is an immune-complex-mediated systemic illness that can occur after treatment with monoclonal or polyclonal antibodies such as Rituxan (Rituximab) or antithymocyte globulin (Thymoglobulin), respectively. Since Rituximab is now being used as an adjuvant treatment for acute humoral reje...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhu, Amarpreet, Harford, Antonia, Singh, Pooja, Alas, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465905/
https://www.ncbi.nlm.nih.gov/pubmed/23056053
http://dx.doi.org/10.1155/2012/234515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465905/
https://www.ncbi.nlm.nih.gov/pubmed/23056053
http://dx.doi.org/10.1155/2012/234515

Ejemplares similares